CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 61 filers reported holding CASI PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$44,0000.0%54,0630.0%0.00%
Q4 2021$44,000
-32.3%
54,0630.0%0.00%
Q3 2021$65,000
-89.7%
54,063
-86.7%
0.00%
Q2 2021$629,000
-48.3%
405,290
-20.0%
0.00%
Q1 2021$1,217,000
-14.1%
506,726
+5.5%
0.00%
-100.0%
Q4 2020$1,417,000
+96.3%
480,106
+1.7%
0.00%
Q3 2020$722,000
-13.7%
471,893
+40.9%
0.00%
Q2 2020$837,000
+34.6%
334,796
+9.8%
0.00%
Q1 2020$622,000
-33.0%
304,894
+1.4%
0.00%
Q4 2019$929,000
+1.6%
300,542
+9.9%
0.00%
-100.0%
Q3 2019$914,000
-8.9%
273,569
-12.7%
0.00%0.0%
Q2 2019$1,003,000
+37.6%
313,252
+23.4%
0.00%
Q1 2019$729,000
-33.7%
253,751
-7.2%
0.00%
-100.0%
Q4 2018$1,100,000
-14.9%
273,396
-1.2%
0.00%0.0%
Q3 2018$1,293,000
+51.1%
276,711
+166.2%
0.00%0.0%
Q2 2018$856,000103,9610.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$19,934,00016.36%
Wellington Shields & Co., LLC 1,585,609$3,964,0001.74%
Wellington Shields Capital Management, LLC 1,321,745$3,304,0000.53%
Ikarian Capital, LLC 1,039,910$2,600,0000.21%
Zebra Capital Management LLC 50,658$127,0000.18%
BOOTHBAY FUND MANAGEMENT, LLC 139,183$348,0000.02%
Manatuck Hill Partners, LLC 15,090$38,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 205,200$513,0000.01%
IHT Wealth Management, LLC 26,000$65,0000.01%
Vident Investment Advisory, LLC 67,540$169,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders